390 related articles for article (PubMed ID: 21532881)
1. Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.
Taylor MA; Amin JD; Kirschmann DA; Schiemann WP
Neoplasia; 2011 May; 13(5):406-18. PubMed ID: 21532881
[TBL] [Abstract][Full Text] [Related]
2. p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity.
Wendt MK; Smith JA; Schiemann WP
J Biol Chem; 2009 Dec; 284(49):34145-56. PubMed ID: 19822523
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
Wendt MK; Schiemann WP
Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
[TBL] [Abstract][Full Text] [Related]
4. Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion.
Galliher AJ; Schiemann WP
Cancer Res; 2007 Apr; 67(8):3752-8. PubMed ID: 17440088
[TBL] [Abstract][Full Text] [Related]
5. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells.
Galliher AJ; Schiemann WP
Breast Cancer Res; 2006; 8(4):R42. PubMed ID: 16859511
[TBL] [Abstract][Full Text] [Related]
6. Regulation of elastin promoter by lysyl oxidase and growth factors: cross control of lysyl oxidase on TGF-beta1 effects.
Oleggini R; Gastaldo N; Di Donato A
Matrix Biol; 2007 Jul; 26(6):494-505. PubMed ID: 17395448
[TBL] [Abstract][Full Text] [Related]
7. Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms.
Neil JR; Johnson KM; Nemenoff RA; Schiemann WP
Carcinogenesis; 2008 Nov; 29(11):2227-35. PubMed ID: 18725385
[TBL] [Abstract][Full Text] [Related]
8. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
Taylor MA; Parvani JG; Schiemann WP
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):169-90. PubMed ID: 20467795
[TBL] [Abstract][Full Text] [Related]
9. Induction of LOX by TGF-β1/Smad/AP-1 signaling aggravates rat myocardial fibrosis and heart failure.
Lu M; Qin Q; Yao J; Sun L; Qin X
IUBMB Life; 2019 Nov; 71(11):1729-1739. PubMed ID: 31317653
[TBL] [Abstract][Full Text] [Related]
10. Noncanonical TGF-β signaling during mammary tumorigenesis.
Parvani JG; Taylor MA; Schiemann WP
J Mammary Gland Biol Neoplasia; 2011 Jun; 16(2):127-46. PubMed ID: 21448580
[TBL] [Abstract][Full Text] [Related]
11. Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism.
Lee YH; Albig AR; Regner M; Schiemann BJ; Schiemann WP
Carcinogenesis; 2008 Dec; 29(12):2243-51. PubMed ID: 18713838
[TBL] [Abstract][Full Text] [Related]
12. The Cain and Abl of epithelial-mesenchymal transition and transforming growth factor-β in mammary epithelial cells.
Allington TM; Schiemann WP
Cells Tissues Organs; 2011; 193(1-2):98-113. PubMed ID: 21051857
[TBL] [Abstract][Full Text] [Related]
13. PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis.
Tian M; Schiemann WP
FASEB J; 2010 Apr; 24(4):1105-16. PubMed ID: 19897661
[TBL] [Abstract][Full Text] [Related]
14. Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β.
Parvani JG; Galliher-Beckley AJ; Schiemann BJ; Schiemann WP
Mol Biol Cell; 2013 Nov; 24(21):3449-59. PubMed ID: 24006485
[TBL] [Abstract][Full Text] [Related]
15. Forkhead Box F1 promotes breast cancer cell migration by upregulating lysyl oxidase and suppressing Smad2/3 signaling.
Nilsson G; Kannius-Janson M
BMC Cancer; 2016 Feb; 16():142. PubMed ID: 26908052
[TBL] [Abstract][Full Text] [Related]
16. Role of Smad2/3 and p38 MAP kinase in TGF-β1-induced epithelial-mesenchymal transition of pulmonary epithelial cells.
Kolosova I; Nethery D; Kern JA
J Cell Physiol; 2011 May; 226(5):1248-54. PubMed ID: 20945383
[TBL] [Abstract][Full Text] [Related]
17. OSR1 phosphorylates the Smad2/3 linker region and induces TGF-β1 autocrine to promote EMT and metastasis in breast cancer.
Li Y; Li L; Qin J; Wu J; Dai X; Xu J
Oncogene; 2021 Jan; 40(1):68-84. PubMed ID: 33051597
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
19. Hypercapnia downregulates hypoxia-induced lysyl oxidase expression in pulmonary artery smooth muscle cells via inhibiting transforming growth factor β
Xia XD; Peng YP; Lei D; Chen WQ
Cell Biochem Funct; 2019 Apr; 37(3):193-202. PubMed ID: 30917408
[TBL] [Abstract][Full Text] [Related]
20. Induction of cardiac fibroblast lysyl oxidase by TGF-β1 requires PI3K/Akt, Smad3, and MAPK signaling.
Voloshenyuk TG; Landesman ES; Khoutorova E; Hart AD; Gardner JD
Cytokine; 2011 Jul; 55(1):90-7. PubMed ID: 21498085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
